Dashboard
Manage Tickers

CINT


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

canaccord-genuity-maintains-buy-on-cit-maintains-8-price-target
Canaccord Genuity Maintains Buy on CI&T, M...
10/16/2025 14:16:46

Canaccord Genuity analyst Luke Morison maintains CI&T (NYSE:CINT) with a Buy and maintains $8 price target.

Core News & Articles
10 Information Technology Stocks Moving In...
10/13/2025 12:09:10

watching-cit-shares-move-higher-hearing-zacks-under-10-newsletter-picks-stock
Watching CI&T; Shares Move Higher, Hearing...
09/16/2025 14:53:37

why-oxford-industries-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket
Why Oxford Industries Shares Are Trading H...
09/11/2025 13:01:10

lovesac-avidity-biosciences-veritone-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Lovesac, Avidity Biosciences, Veritone And...
09/11/2025 12:08:59

Core News & Articles
12 Information Technology Stocks Moving In...
08/14/2025 12:08:39

cit-expects-fy-2025-revenue-to-rise-105-150-yoy
CI&T expects FY 2025 revenue to rise 10.5%...
08/13/2025 21:42:34

CI&T (NYSE:CINT) expects FY 2025 revenue to rise 10.5%-15.0% YoY

cit-q3--revenue-expected-to-be-more-than-124400m-vs-123662m-est
CI&T Q3 Revenue expected to be more than ...
08/13/2025 21:32:26

CI&T (NYSE:CINT) Q3 Revenue expected to be more than $124.400M vs $123.662M Est

Core News & Articles
12 Information Technology Stocks Moving In...
08/13/2025 21:06:04

cit-q2-adj-eps-009-inline-sales-117200m-beat-117058m-estimate
CI&T Q2 Adj. EPS $0.09, Inline, Sales $117...
08/13/2025 20:17:59

CI&T (NYSE:CINT) reported quarterly earnings of $0.09 per share which met the analyst consensus estimate. This is unchanged...

Core News & Articles
Earnings Scheduled For August 13, 2025
08/13/2025 08:32:30

insights-ahead-cits-quarterly-earnings
Insights Ahead: CI&T's Quarterly Earnings
08/12/2025 15:02:26

where-cit-stands-with-analysts
Where CI&T Stands With Analysts
07/22/2025 22:00:21

ubs-maintains-neutral-on-cit-lowers-price-target-to-68
UBS Maintains Neutral on CI&T, Lowers Pric...
07/22/2025 13:57:12

UBS analyst Leonardo Olmos maintains CI&T (NYSE:CINT) with a Neutral and lowers the price target from $8 to $6.8.

Core News & Articles
12 Information Technology Stocks Moving In...
05/27/2025 21:06:01

Core News & Articles
12 Information Technology Stocks Moving In...
05/21/2025 12:07:21

Core News & Articles
CI&T, Novavax, Paramount Group And Other B...
05/19/2025 14:21:05

this-united-airlines-analyst-turns-bullish-here-are-top-5-upgrades-for-monday
This United Airlines Analyst Turns Bullish...
05/19/2025 12:02:31

jp-morgan-upgrades-cit-to-overweight-announces-7-price-target
JP Morgan Upgrades CI&T to Overweight, Ann...
05/19/2025 11:14:06

JP Morgan analyst Puneet Jain upgrades CI&T (NYSE:CINT) from Neutral to Overweight and announces $7 price target.

cit-q2--revenue-expected-to-be-more-than-11550m-vs-11171m-est
CI&T Q2 Revenue expected to be more than ...
05/13/2025 20:31:35

CI&T (NYSE:CINT) Q2 Revenue expected to be more than $115.50M vs $111.71M Est

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION